Skip to main content
Top
Published in: Inflammation 5/2007

01-10-2007

Platelet Activation During Allergic Inflammation

Authors: Alicja Kasperska-Zajac, Barbara Rogala

Published in: Inflammation | Issue 5/2007

Login to get access

Abstract

Blood platelets, apart from their traditional and well-recognised function in haemostasis, play an essential and active role in allergic inflammation e.g. through their participation in cell recruitment from blood to site of immune reactivity as a result of direct interactions with leukocytes, and through the release of inflammatory mediators. Platelet activation may occur during human allergic reactions both systemically and locally at the site of allergic inflammation as a result of an IgE-dependent process and as a secondary event caused by other inflammatory or immune stimuli. Altered platelet function as measured by platelet secretion, expression of surface molecules, aggregation, adhesion or arachidonic acid metabolism has been found in patients suffering from allergic diseases. These blood elements have been implicated in the pathogenesis of allergic diseases associated with the so-called atopic diathesis. This paper reviews the platelet activity and reactivity in allergic inflammation, along with our own findings concerning platelet release reaction and the phenomenon of platelet aggregation in patients with different clinical forms of allergy.
Literature
1.
go back to reference Capron, M., T. Jouault, L. Prin, M. Joseph, J. C. Ameisen, A. F. Butterworth, J. P. Papin, J. P. Kusnierz, and A. Capron. 1986. Functional study of a monoclonal antibody to IgE Fcɛ receptor (FcɛR2) of eosinophils, platelets and macrophages. J. Exp. Med. 164:72–89.PubMedCrossRef Capron, M., T. Jouault, L. Prin, M. Joseph, J. C. Ameisen, A. F. Butterworth, J. P. Papin, J. P. Kusnierz, and A. Capron. 1986. Functional study of a monoclonal antibody to IgE Fcɛ receptor (FcɛR2) of eosinophils, platelets and macrophages. J. Exp. Med. 164:72–89.PubMedCrossRef
2.
go back to reference Joseph, M., A. Capron, J. C. Ameisen, M. Capron, H. Vorng, V. Pancré, J. P. Kusnierz, and C Auriault. 1986. The receptor for IgE on blood platelets. Eur. J. Immunol. 16:306–312.PubMedCrossRef Joseph, M., A. Capron, J. C. Ameisen, M. Capron, H. Vorng, V. Pancré, J. P. Kusnierz, and C Auriault. 1986. The receptor for IgE on blood platelets. Eur. J. Immunol. 16:306–312.PubMedCrossRef
3.
go back to reference Joseph, M., A. S. Gounni, J. P. Kusnierz, H. Vorng, M. Sarfati, J. P. Kinet, A. B. Tonnel, A. Capron, and M. Capron. 1997. Expression and function of the high-affinity IgE receptor on human platelets and megakaryocyte precursors. Eur. J. Immunol. 27:2212–2218.PubMedCrossRef Joseph, M., A. S. Gounni, J. P. Kusnierz, H. Vorng, M. Sarfati, J. P. Kinet, A. B. Tonnel, A. Capron, and M. Capron. 1997. Expression and function of the high-affinity IgE receptor on human platelets and megakaryocyte precursors. Eur. J. Immunol. 27:2212–2218.PubMedCrossRef
4.
go back to reference Hasegawa, S., R. Pawankar, K. Suzuki, T. Nakahata, S. Furukawa, K. Okumura, and C. Ra. 1999. Functional expression of the high affinity receptor for IgE (FcɛRI) in human platelets and its’ intracellular expression in human megacariocytes. Blood 93:2543–2551.PubMed Hasegawa, S., R. Pawankar, K. Suzuki, T. Nakahata, S. Furukawa, K. Okumura, and C. Ra. 1999. Functional expression of the high affinity receptor for IgE (FcɛRI) in human platelets and its’ intracellular expression in human megacariocytes. Blood 93:2543–2551.PubMed
5.
go back to reference De Sousa, J. R., M. C. Santos, M. L. Carlos, and A. G. Carlos. 1992. Platelet reactivity to ‘in vitro’ allergen challenge in asthmatic patients. Allergol. Immunopathol. 20:13–16. De Sousa, J. R., M. C. Santos, M. L. Carlos, and A. G. Carlos. 1992. Platelet reactivity to ‘in vitro’ allergen challenge in asthmatic patients. Allergol. Immunopathol. 20:13–16.
6.
go back to reference Danese, S., C. de la Motte, B. M. Reyes, M. Sans, A. D. Levine, and C. Fiocchi. 2004. Cutting edge: T cells trigger CD40-dependent platelet activation and granular RANTES release: a novel pathway for immune response amplification. J. Immunol. 172:2011–2015.PubMed Danese, S., C. de la Motte, B. M. Reyes, M. Sans, A. D. Levine, and C. Fiocchi. 2004. Cutting edge: T cells trigger CD40-dependent platelet activation and granular RANTES release: a novel pathway for immune response amplification. J. Immunol. 172:2011–2015.PubMed
7.
go back to reference Weyrich, A. S., M. R. Elstad, R. P. McEver, T. M. McIntyre, K. L. Moore, J. H. Morrissey, S. M. Prescott, and G. A. Zimmerman. 1996. Activated platelets signal chemokine synthesis by human monocytes. J. Clin. Invest. 97:1525–1534.PubMedCrossRef Weyrich, A. S., M. R. Elstad, R. P. McEver, T. M. McIntyre, K. L. Moore, J. H. Morrissey, S. M. Prescott, and G. A. Zimmerman. 1996. Activated platelets signal chemokine synthesis by human monocytes. J. Clin. Invest. 97:1525–1534.PubMedCrossRef
8.
go back to reference Czapiga, M., A. D. Kirk, J. Lekstrom-Himes. 2004. Platelets deliver costimulatory signals to antigen-presenting cells: a potential bridge between injury and immune activation. Exp. Hematol. 32:135–139.PubMedCrossRef Czapiga, M., A. D. Kirk, J. Lekstrom-Himes. 2004. Platelets deliver costimulatory signals to antigen-presenting cells: a potential bridge between injury and immune activation. Exp. Hematol. 32:135–139.PubMedCrossRef
9.
go back to reference Kaplan, K. L., and J. Owen. 1981. Plasma levels of β-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 57:199–202.PubMed Kaplan, K. L., and J. Owen. 1981. Plasma levels of β-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 57:199–202.PubMed
10.
go back to reference Hayashi, N., J. Chihara, Y. Kobayashi, T. Kakazu, D. Kurachi, T. Yamamoto, and S. Nakajima. 1994. Effect of platelet-activating factor and platelet factor 4 on eosinophil adhesion. Int. Arch. Allergy Immunol. 104(Suppl):57–59.PubMedCrossRef Hayashi, N., J. Chihara, Y. Kobayashi, T. Kakazu, D. Kurachi, T. Yamamoto, and S. Nakajima. 1994. Effect of platelet-activating factor and platelet factor 4 on eosinophil adhesion. Int. Arch. Allergy Immunol. 104(Suppl):57–59.PubMedCrossRef
11.
go back to reference Teran, L. M., and D. E. Davies. 1996. The chemokines: their potential role in allergic inflammation. Clin. Exp. Allergy 26:1005–1019.PubMedCrossRef Teran, L. M., and D. E. Davies. 1996. The chemokines: their potential role in allergic inflammation. Clin. Exp. Allergy 26:1005–1019.PubMedCrossRef
12.
go back to reference Orchard, M. A., A. Kagey-Sobotka, D. Proud, and L. M. Lichtenstein. 1986. Basophil histamine release induced by a substance from stimulated human platelets. J. Immunol. 136:2240–2244.PubMed Orchard, M. A., A. Kagey-Sobotka, D. Proud, and L. M. Lichtenstein. 1986. Basophil histamine release induced by a substance from stimulated human platelets. J. Immunol. 136:2240–2244.PubMed
13.
go back to reference Suzuki, R., T. Kimura, K. Kitaichi, Y. Tatsumi, M. Matsushima, Y. L. Zhao, E. Shibata, K. Baba, T. Hasegawa, and K. Takagi. 2002. Platelet factor 4 fragment induces histamine release from rate peritoneal mast cells. Peptides 23:1713–1717.PubMedCrossRef Suzuki, R., T. Kimura, K. Kitaichi, Y. Tatsumi, M. Matsushima, Y. L. Zhao, E. Shibata, K. Baba, T. Hasegawa, and K. Takagi. 2002. Platelet factor 4 fragment induces histamine release from rate peritoneal mast cells. Peptides 23:1713–1717.PubMedCrossRef
14.
go back to reference Pitchford, S. C., H. Yano, R. Lever, Y. Riffo-Vasquez, S. Ciferri, M. J. Rose, S. Giannini, S. Momi, D. Spina, B. O’Connor, P. Gresele, and C. P. Page. 2003. Platelets are essential for leukocyte recruitment in allergic inflammation. J. Allergy Clin. Immunol. 112:109–118.PubMedCrossRef Pitchford, S. C., H. Yano, R. Lever, Y. Riffo-Vasquez, S. Ciferri, M. J. Rose, S. Giannini, S. Momi, D. Spina, B. O’Connor, P. Gresele, and C. P. Page. 2003. Platelets are essential for leukocyte recruitment in allergic inflammation. J. Allergy Clin. Immunol. 112:109–118.PubMedCrossRef
15.
go back to reference Pitchford, S. C., S. Momi, S. Giannini, L. Casali, D. Spina, C. P. Page, and P. Gresele. 2005. Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation. Blood 105:2074–2081.PubMedCrossRef Pitchford, S. C., S. Momi, S. Giannini, L. Casali, D. Spina, C. P. Page, and P. Gresele. 2005. Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation. Blood 105:2074–2081.PubMedCrossRef
16.
go back to reference Averill, F. J., W. C. Hubbard, D. Proud, G. J. Gleich, and M. C. Lin. 1992. Platelet activation in the lung after antigen challenge in a model of allergic asthma. Am. Rev. Respir. Dis. 145:571–576.PubMed Averill, F. J., W. C. Hubbard, D. Proud, G. J. Gleich, and M. C. Lin. 1992. Platelet activation in the lung after antigen challenge in a model of allergic asthma. Am. Rev. Respir. Dis. 145:571–576.PubMed
17.
go back to reference Knauer, K. A., L. M. Lichtenstein, N. F. Adkinson, and J. E. Fish. 1981. Platelet activation during antigen-mediated airway reactions in asthmatic subjects. N. Engl. J. Med. 304:1404–1407.PubMedCrossRef Knauer, K. A., L. M. Lichtenstein, N. F. Adkinson, and J. E. Fish. 1981. Platelet activation during antigen-mediated airway reactions in asthmatic subjects. N. Engl. J. Med. 304:1404–1407.PubMedCrossRef
18.
go back to reference Kowal, K., A. Pampuch, O. Kowal-Bielecka, L. M. DuBuske, and A. Bodzenta-Łukaszyk. 2005. Platelet activation in allergic asthma patients during allergen challenge with Dermatophagoides pteronyssinus. Clin. Exp. Allergy 36:426–432.CrossRef Kowal, K., A. Pampuch, O. Kowal-Bielecka, L. M. DuBuske, and A. Bodzenta-Łukaszyk. 2005. Platelet activation in allergic asthma patients during allergen challenge with Dermatophagoides pteronyssinus. Clin. Exp. Allergy 36:426–432.CrossRef
19.
go back to reference Yamamoto, H., M. Nagata, K. Tabe, I. Kimura, H. Kiuchi, Y. Sakamoto, K. Yamamoto, and Y. Dohi. 1993. The evidence of platelet activation in bronchial asthma. J. Allergy Clin. Immunol. 91:79–87.PubMedCrossRef Yamamoto, H., M. Nagata, K. Tabe, I. Kimura, H. Kiuchi, Y. Sakamoto, K. Yamamoto, and Y. Dohi. 1993. The evidence of platelet activation in bronchial asthma. J. Allergy Clin. Immunol. 91:79–87.PubMedCrossRef
20.
go back to reference Morrison, J. F. J., S. B. Pearson, H. G. Dean, I. R. Craig, and P. N. Bramley. 1991. Platelet activation in nocturnal asthma. Thorax 46:197–200.PubMedCrossRef Morrison, J. F. J., S. B. Pearson, H. G. Dean, I. R. Craig, and P. N. Bramley. 1991. Platelet activation in nocturnal asthma. Thorax 46:197–200.PubMedCrossRef
21.
go back to reference Maccia, C. A, J. S. Gallagher, G. Ataman, H. I. Glueck, S. M. Brooks, and I. L. Bernstein. 1977. Platelet thrombopathy in asthmatic patients with elevated immunoglobuline E. J. Allergy Clin. Immunol. 59:101–108.PubMedCrossRef Maccia, C. A, J. S. Gallagher, G. Ataman, H. I. Glueck, S. M. Brooks, and I. L. Bernstein. 1977. Platelet thrombopathy in asthmatic patients with elevated immunoglobuline E. J. Allergy Clin. Immunol. 59:101–108.PubMedCrossRef
22.
go back to reference Pareti, F. I., A. Capitanio, L. Mannucci, C. Ponticelli, and P. M. Mannucci. 1980. Acquired dysfunction due to the circulation of “exhausted” platelets. Am. J. Med. 69:235–240.PubMedCrossRef Pareti, F. I., A. Capitanio, L. Mannucci, C. Ponticelli, and P. M. Mannucci. 1980. Acquired dysfunction due to the circulation of “exhausted” platelets. Am. J. Med. 69:235–240.PubMedCrossRef
23.
go back to reference Taytard, A., H. Guenard, L. Vuillemin, J. L. Bouvot, J. Vergeret, D. Ducassou, Y. Piquet, and P. Freour. 1986. Platelet kinetics in stable atopic asthmatic patients. Am. Rev. Respir. Dis. 134:983–985.PubMed Taytard, A., H. Guenard, L. Vuillemin, J. L. Bouvot, J. Vergeret, D. Ducassou, Y. Piquet, and P. Freour. 1986. Platelet kinetics in stable atopic asthmatic patients. Am. Rev. Respir. Dis. 134:983–985.PubMed
24.
go back to reference Moritani, C., S. Ishioka, Y. Haruta, M. Kambe, and M. Yamakido. 1998. Activation of platelets in bronchial asthma. Chest 113:452–458.PubMed Moritani, C., S. Ishioka, Y. Haruta, M. Kambe, and M. Yamakido. 1998. Activation of platelets in bronchial asthma. Chest 113:452–458.PubMed
25.
go back to reference Heng, W., G. Wang, and Z. Wang. 2000. The role of platelet activation in the pathogenesis of asthma. Zhonghua Jie He He Hu Za Zhi 23:343–346. Heng, W., G. Wang, and Z. Wang. 2000. The role of platelet activation in the pathogenesis of asthma. Zhonghua Jie He He Hu Za Zhi 23:343–346.
26.
go back to reference Edenius, C., L. Stenke, and J. A. Lindgren. 1991. On the mechanism of transcellular lipoxin formation in human platelets and granulocytes. Eur. J. Biochem. 199:401–409.PubMedCrossRef Edenius, C., L. Stenke, and J. A. Lindgren. 1991. On the mechanism of transcellular lipoxin formation in human platelets and granulocytes. Eur. J. Biochem. 199:401–409.PubMedCrossRef
27.
go back to reference Kantarci A., and T. E. Van-Dyke. 2003. Lipoxins in chronic inflammation. Crit. Rev. Oral. Biol. Med. 14:4–12.PubMed Kantarci A., and T. E. Van-Dyke. 2003. Lipoxins in chronic inflammation. Crit. Rev. Oral. Biol. Med. 14:4–12.PubMed
28.
go back to reference Barnes, P. J. 1987. Inflammatory mediator receptors and asthma. Am. Rev. Respir. Dis. 135:S26–S31.PubMed Barnes, P. J. 1987. Inflammatory mediator receptors and asthma. Am. Rev. Respir. Dis. 135:S26–S31.PubMed
29.
go back to reference Iwamoto, I., C. Ra, T. Sato, H. Tomioka, and S. Yoshida. 1988. Thromboxane A2 production in allergen-induced immediate and late asthmatic responses. Its possible role in inducing the late response. J. Asthma 25:117–124.PubMed Iwamoto, I., C. Ra, T. Sato, H. Tomioka, and S. Yoshida. 1988. Thromboxane A2 production in allergen-induced immediate and late asthmatic responses. Its possible role in inducing the late response. J. Asthma 25:117–124.PubMed
30.
go back to reference Levy, B. D., G. T. De Sanctis, P. R. Devchand, E. Kim, K. Ackerman, B. A. Schmidt, W. Szczeklik, J. M. Drazen, and C. N. Serhan. 2002. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat. Med. 8:1018–1023.PubMedCrossRef Levy, B. D., G. T. De Sanctis, P. R. Devchand, E. Kim, K. Ackerman, B. A. Schmidt, W. Szczeklik, J. M. Drazen, and C. N. Serhan. 2002. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat. Med. 8:1018–1023.PubMedCrossRef
31.
go back to reference Yoshimi, Y., M. Fujimura, S. Myou, H. Tachibana, and T. Hirose. 2001. Effect of thromboxane A2 (TXA2) synthase inhibitor and TXA2 receptor antagonist alone and in combination on antigen-induced bronchoconstriction in guinea pigs. Prostaglandins Other Lipid Mediat. 65:1–9.PubMedCrossRef Yoshimi, Y., M. Fujimura, S. Myou, H. Tachibana, and T. Hirose. 2001. Effect of thromboxane A2 (TXA2) synthase inhibitor and TXA2 receptor antagonist alone and in combination on antigen-induced bronchoconstriction in guinea pigs. Prostaglandins Other Lipid Mediat. 65:1–9.PubMedCrossRef
32.
go back to reference Pitchford, S. C., Y. Riffo-Vasquez, A. Sousa, S. Momi, P. Gresele, and C. P. Page. 2004. Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation. Blood 103:639–647.PubMedCrossRef Pitchford, S. C., Y. Riffo-Vasquez, A. Sousa, S. Momi, P. Gresele, and C. P. Page. 2004. Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation. Blood 103:639–647.PubMedCrossRef
33.
go back to reference Kasperska-Zajac, A., and B. Rogala. 2003. Platelet activity measured by plasma levels of beta-thromboglobulin and platelet factor 4 in seasonal allergic rhinitis during natural pollen exposure. Inflamm. Res. 52:477–479.PubMedCrossRef Kasperska-Zajac, A., and B. Rogala. 2003. Platelet activity measured by plasma levels of beta-thromboglobulin and platelet factor 4 in seasonal allergic rhinitis during natural pollen exposure. Inflamm. Res. 52:477–479.PubMedCrossRef
34.
go back to reference Kasperska-Zajac, A., and B. Rogala. 2005. Markers of platelet activation in plasma of patients suffering from persistent allergic rhinitis with or without asthma symptoms. Clin. Exp. Allergy. 35:1462–1465.PubMedCrossRef Kasperska-Zajac, A., and B. Rogala. 2005. Markers of platelet activation in plasma of patients suffering from persistent allergic rhinitis with or without asthma symptoms. Clin. Exp. Allergy. 35:1462–1465.PubMedCrossRef
35.
go back to reference Kasperska-Zajac A., Z. Brzoza, and B. Rogala. 2006. Effect of allergen-specific immunotherapy on platelet secretory activity in patients with grass-pollen allergy. Vaccine 24(47–48):6990–6993.PubMedCrossRef Kasperska-Zajac A., Z. Brzoza, and B. Rogala. 2006. Effect of allergen-specific immunotherapy on platelet secretory activity in patients with grass-pollen allergy. Vaccine 24(47–48):6990–6993.PubMedCrossRef
36.
go back to reference Hanifin, J., and G. Rajka. 1980. Diagnostic features of atopic dermatitis. Acta Derm. Venereol. (Stockh.). 92(Suppl):44–47. Hanifin, J., and G. Rajka. 1980. Diagnostic features of atopic dermatitis. Acta Derm. Venereol. (Stockh.). 92(Suppl):44–47.
37.
go back to reference Hilger, R. A., K. Neuber, and W. König 1991. Conversion of leukotriene A4 by neutrophils and platelets from patients with atopic dermatitis. Immunology 74:689–695.PubMed Hilger, R. A., K. Neuber, and W. König 1991. Conversion of leukotriene A4 by neutrophils and platelets from patients with atopic dermatitis. Immunology 74:689–695.PubMed
38.
go back to reference Neuber, K., R. A. Hilger, and W. König. 1992. Differential increase in 12-HETE release and CD29/CD49f expression of platelets from normal donors and from patients with atopic dermatitis. Int. Arch. Allergy Immunol. 98:339–342.PubMedCrossRef Neuber, K., R. A. Hilger, and W. König. 1992. Differential increase in 12-HETE release and CD29/CD49f expression of platelets from normal donors and from patients with atopic dermatitis. Int. Arch. Allergy Immunol. 98:339–342.PubMedCrossRef
39.
go back to reference Watanabe, O., K. Natori, M. Tamari, Y. Shiomoto, S. Kubo, and Y. Nakamura. 1999. Significantly elevated expression of PF4 (platelet factor 4) and eotaxin in the NOA mouse, a model for atopic dermatitis. J. Hum. Genet. 44:173–176.PubMedCrossRef Watanabe, O., K. Natori, M. Tamari, Y. Shiomoto, S. Kubo, and Y. Nakamura. 1999. Significantly elevated expression of PF4 (platelet factor 4) and eotaxin in the NOA mouse, a model for atopic dermatitis. J. Hum. Genet. 44:173–176.PubMedCrossRef
40.
go back to reference Kasperska-Zajac, A., M. Nowakowski, and B. Rogala. 2004. Enhanced platelet activation in patients with atopic eczema/dermatitis syndrome. Inflammation. 28:299–302.CrossRefPubMed Kasperska-Zajac, A., M. Nowakowski, and B. Rogala. 2004. Enhanced platelet activation in patients with atopic eczema/dermatitis syndrome. Inflammation. 28:299–302.CrossRefPubMed
41.
go back to reference Bruijnzeel, P. L. B., P. H. M., Kuijper, S. Rihs, S. Betz, R. A. J. Warringa, and L. Koenderman. 1993. Eosinophil migration in atopic dermatitis. I. Increased migratory responses to N-formyl-methionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet activating factor, and platelet factor 4. J. Invest. Dermatol. 100:137–142.PubMedCrossRef Bruijnzeel, P. L. B., P. H. M., Kuijper, S. Rihs, S. Betz, R. A. J. Warringa, and L. Koenderman. 1993. Eosinophil migration in atopic dermatitis. I. Increased migratory responses to N-formyl-methionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet activating factor, and platelet factor 4. J. Invest. Dermatol. 100:137–142.PubMedCrossRef
42.
go back to reference Rogala, B., J.Gumprecht, R. Gawlik, and E. Rogala. 1995. Platelet aggregation in IgE-mediated allergy with elevated soluble FcɛRII/CD23 level. J. Invest. Allergol. Clin. Immunol. 5:161–165. Rogala, B., J.Gumprecht, R. Gawlik, and E. Rogala. 1995. Platelet aggregation in IgE-mediated allergy with elevated soluble FcɛRII/CD23 level. J. Invest. Allergol. Clin. Immunol. 5:161–165.
43.
go back to reference Rogala, B., J. Gumprecht, and K. Strojek. 1993. Agregacja płytek i ekspresja receptora o niskim powinowactwie dla IgE Fcɛ RII (CD23) u chorych na pyłkowicę. Pnenum. Alergol. Pol. 61:133–137. Rogala, B., J. Gumprecht, and K. Strojek. 1993. Agregacja płytek i ekspresja receptora o niskim powinowactwie dla IgE Fcɛ RII (CD23) u chorych na pyłkowicę. Pnenum. Alergol. Pol. 61:133–137.
44.
go back to reference Maccia, C. A., J. S. Gallagher, G. Ataman, H. I. Glueck, S. M. Brooks, and I. L Bernstein. 1977. Platelet thrombopathy in asthmatic patients with elevated immunoglobulin E. J. Allergy Clin. Immunol. 59:101–108.PubMedCrossRef Maccia, C. A., J. S. Gallagher, G. Ataman, H. I. Glueck, S. M. Brooks, and I. L Bernstein. 1977. Platelet thrombopathy in asthmatic patients with elevated immunoglobulin E. J. Allergy Clin. Immunol. 59:101–108.PubMedCrossRef
45.
go back to reference Gallagher, J. S., I. L. Bernstein, C. A. Maccia, G. L. Splansky, and H. I. Glueck. 1978. Cyclic platelet dysfunction in IgE-mediated allergy. J. Allergy Clin. Immunol. 62:229–235.PubMedCrossRef Gallagher, J. S., I. L. Bernstein, C. A. Maccia, G. L. Splansky, and H. I. Glueck. 1978. Cyclic platelet dysfunction in IgE-mediated allergy. J. Allergy Clin. Immunol. 62:229–235.PubMedCrossRef
46.
go back to reference Szczeklik, A., P. C. Milner, J. Birch, J. Watkins, and J. F. Martin. 1986. Prolonged bleeding time, reduced platelet aggregation, altered PAF-acether sensitivity and increased platelet mass are a trait of asthma and hay fever. Thromb. Haemost. 56:283–287.PubMed Szczeklik, A., P. C. Milner, J. Birch, J. Watkins, and J. F. Martin. 1986. Prolonged bleeding time, reduced platelet aggregation, altered PAF-acether sensitivity and increased platelet mass are a trait of asthma and hay fever. Thromb. Haemost. 56:283–287.PubMed
47.
go back to reference Rogala, B., J. Gumprecht, and J. Glück. 1999. Platelet aggregation in atopic dermatitis. Platelets. 10:341–344.PubMedCrossRef Rogala, B., J. Gumprecht, and J. Glück. 1999. Platelet aggregation in atopic dermatitis. Platelets. 10:341–344.PubMedCrossRef
Metadata
Title
Platelet Activation During Allergic Inflammation
Authors
Alicja Kasperska-Zajac
Barbara Rogala
Publication date
01-10-2007
Publisher
Springer US
Published in
Inflammation / Issue 5/2007
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-007-9033-3

Other articles of this Issue 5/2007

Inflammation 5/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine